Logo image of TLIK.DE

ARZNEIWERK AG VIDA (TLIK.DE) Stock Fundamental Analysis

FRA:TLIK - Deutsche Boerse Ag - DE000A289B07 - Common Stock - Currency: EUR

0.486  0 (0%)

Fundamental Rating

1

Taking everything into account, TLIK scores 1 out of 10 in our fundamental rating. TLIK was compared to 23 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of TLIK have multiple concerns. TLIK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TLIK has reported negative net income.
In the past year TLIK has reported a negative cash flow from operations.
In multiple years TLIK reported negative net income over the last 5 years.
In multiple years TLIK reported negative operating cash flow during the last 5 years.
TLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFTLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -18.11%, TLIK is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.11%
ROE N/A
ROIC N/A
ROA(3y)-50.09%
ROA(5y)11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLIK.DE Yearly ROA, ROE, ROICTLIK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

TLIK has a Gross Margin of 6.17%. This is in the lower half of the industry: TLIK underperforms 76.92% of its industry peers.
In the last couple of years the Gross Margin of TLIK has declined.
TLIK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-59.12%
GM growth 5Y-38.57%
TLIK.DE Yearly Profit, Operating, Gross MarginsTLIK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

0

2. Health

2.1 Basic Checks

TLIK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLIK remains at a similar level compared to 1 year ago.
TLIK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TLIK is higher compared to a year ago.
TLIK.DE Yearly Shares OutstandingTLIK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
TLIK.DE Yearly Total Debt VS Total AssetsTLIK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that TLIK is in the distress zone and has some risk of bankruptcy.
TLIK has a Altman-Z score (1.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.17
ROIC/WACCN/A
WACC4.5%
TLIK.DE Yearly LT Debt VS Equity VS FCFTLIK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.63 indicates that TLIK may have some problems paying its short term obligations.
TLIK has a Current ratio of 0.63. This is in the lower half of the industry: TLIK underperforms 69.23% of its industry peers.
A Quick Ratio of 0.26 indicates that TLIK may have some problems paying its short term obligations.
TLIK's Quick ratio of 0.26 is on the low side compared to the rest of the industry. TLIK is outperformed by 80.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.26
TLIK.DE Yearly Current Assets VS Current LiabilitesTLIK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

3

3. Growth

3.1 Past

TLIK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.64%, which is quite impressive.
Looking at the last year, TLIK shows a very negative growth in Revenue. The Revenue has decreased by -19.21% in the last year.
TLIK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 62.08% yearly.
EPS 1Y (TTM)82.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.14%
Revenue 1Y (TTM)-19.21%
Revenue growth 3Y176.64%
Revenue growth 5Y62.08%
Sales Q2Q%-0.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLIK.DE Yearly Revenue VS EstimatesTLIK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
TLIK.DE Yearly EPS VS EstimatesTLIK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLIK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLIK.DE Price Earnings VS Forward Price EarningsTLIK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLIK.DE Per share dataTLIK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TLIK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARZNEIWERK AG VIDA

FRA:TLIK (3/6/2025, 7:00:00 PM)

0.486

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)04-28 2025-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners34.31%
Ins Owner ChangeN/A
Market Cap3.03M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS9.58
BVpS-0.8
TBVpS-0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.17%
FCFM N/A
ROA(3y)-50.09%
ROA(5y)11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-59.12%
GM growth 5Y-38.57%
F-Score2
Asset Turnover4.91
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.65%
Cap/Sales 0.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.26
Altman-Z 1.17
F-Score2
WACC4.5%
ROIC/WACCN/A
Cap/Depr(3y)64.75%
Cap/Depr(5y)48.85%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.21%
Revenue growth 3Y176.64%
Revenue growth 5Y62.08%
Sales Q2Q%-0.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.91%
OCF growth 3YN/A
OCF growth 5YN/A